SSCM
RMD icon

Sovereign's Capital Management’s ResMed RMD Stock Holding History

Sovereign's Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Sell
955
-2,480
-72% -$618K 0.16% 74
2025
Q4 		$827K Sell
3,435
-4,404
-56% -$1.13M 0.5% 46
2025
Q3 		$2.15M Sell
7,839
-893
-10% -$244K 1.16% 34
2025
Q2 		$2.25M Buy
8,732
+896
+11% +$214K 1.21% 33
2025
Q1 		$1.75M Buy
7,836
+2,540
+48% +$593K 1.04% 35
2024
Q4 		$1.21M Buy
+5,296
New +$1.28M 0.77% 45

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sovereign's Capital Management's RMD Position: Q1 2026 in Review

Sovereign's Capital Management reduced its ResMed (RMD) stake by 72% in Q1 2026, selling an estimated $618K and leaving 955 shares worth $214K. The position accounts for 0.16% of the portfolio, ranked #74.

Sovereign's Capital Management first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.25M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Sovereign's Capital Management held 955 shares of ResMed worth $214K as of Q1 2026.
  • Sovereign's Capital Management sold 2,480 ResMed shares in Q1 2026, an estimated $618K.
  • ResMed made up 0.16% of Sovereign's Capital Management's portfolio in Q1 2026, its #74 holding.
  • Sovereign's Capital Management first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Sovereign's Capital Management's ResMed position peaked at $2.25M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Sovereign's Capital Management's 13F filing for Q1 2026, filed 15 May 2026.